These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 19927485

  • 1. Topical apraclonidine to diagnose Bernard-Horner syndrome.
    Kocabora M, Gocmez E, Taskapili M.
    Bull Soc Belge Ophtalmol; 2009; (312):9-15. PubMed ID: 19927485
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY.
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [Abstract] [Full Text] [Related]

  • 4. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
    Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E.
    Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449
    [Abstract] [Full Text] [Related]

  • 5. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.
    Chen PL, Chen JT, Lu DW, Chen YC, Hsiao CH.
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):182-7. PubMed ID: 16808679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
    Bacal DA, Levy SR.
    Arch Ophthalmol; 2004 Feb; 122(2):276-9. PubMed ID: 14769608
    [No Abstract] [Full Text] [Related]

  • 9. Early diagnosis of Horner syndrome using topical apraclonidine.
    Cooper-Knock J, Pepper I, Hodgson T, Sharrack B.
    J Neuroophthalmol; 2011 Sep; 31(3):214-6. PubMed ID: 21566530
    [Abstract] [Full Text] [Related]

  • 10. Using apraclonidine in diagnosing Horner syndrome in children.
    Sueke H, Chandna A.
    Am J Ophthalmol; 2010 May; 149(5):869; author reply 870. PubMed ID: 20399934
    [No Abstract] [Full Text] [Related]

  • 11. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA, González I, Fernández FJ, Díaz S, Ferrer C, Alias E, Honrubia FM.
    Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ, Yang HK, Hwang JM.
    PLoS One; 2017 Feb; 12(6):e0178361. PubMed ID: 28575101
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P, Satterfield D, Lim MK.
    J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343
    [Abstract] [Full Text] [Related]

  • 15. Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
    Koc F, Kansu T, Kavuncu S, Firat E.
    J Neuroophthalmol; 2006 Mar; 26(1):25-9. PubMed ID: 16518162
    [Abstract] [Full Text] [Related]

  • 16. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM, Aouchiche R, Freedman KA.
    Arch Ophthalmol; 2003 Aug; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract] [Full Text] [Related]

  • 17. Ocular effects of apraclonidine in Horner syndrome.
    Morales J, Brown SM, Abdul-Rahim AS, Crosson CE.
    Arch Ophthalmol; 2000 Jul; 118(7):951-4. PubMed ID: 10900109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
    Nguyen MTB, Farahvash A, Zhang A, Micieli JA.
    J Neurol Sci; 2020 Dec 15; 419():117190. PubMed ID: 33075593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.